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Introduction:
The growth and metastatic potential of breast cancer cells are regulated by estrogen, a ligand of the estrogen receptors (ERs) (1, 2) . The ERs facilitate major effects of estrogen in cells through interactions with transcriptional cofactors to regulate transcription of ERtargeting genes. We previously identified two human cofactors TIP30 and CIA (Coativator Independent of AF2) that can specifically regulate ERa-mediated transcription. TIP30, also called CC3 or Htatip2, is a tumor suppressor that can promote apoptosis and inhibits angiogensis, through the regulation of transcription (3) (4) (5) . TIP30 interacts with an ERainteracting coactivator CIA (6, 7) . Therefore, we hypothesized that overexpression of both TIP30 and CIA will inhibit transcription of ER-target genes such as c-Myc and Cyclin D1 and overexpression of TIP30 and CIA in ER-negative MDA-MB-231 breast cancer cells suppresses cell growth. We proposed to determine the effects of TIP30 and CIA on expression of ERa-responsive genes, such as c-Myc and Cyclin DI in the first year. Now, we show that TIP30 overexpression represses ERca-mediated c-myc transcription, whereas TIP30 deficiency enhances c-myc transcription in the absence and presence of estrogen. Ectopic CIA cooperates with TIP30 to repress ERa-mediated c-myc transcription. Using chromatin immunoprecipitation (ChIP) assays (8) , we demonstrate that TIP30 and CIA are distinct cofactors that are dynamically associated with transcription initiation and elongation complexes in response to estrogen. Both TIP30 and CIA are recruited to the cmyc gene promoter by liganded ERca in the second transcription cycle. Overexpression of TIP30 and CIA in ER-negative MDA-MB-231 breast cancer cells suppresses cell growth. a. CIA and TIP30 act as co-regulators in ERa-mediated transcription. Transcription of the c-myc gene is controlled by transcription factors that interact with numerous positive and negative regulatory elements in the c-myc promoter regions. ERa can stimulate c-myc transcription by interacting with an estrogen-responsive element of the c-myc promoter. To test whether CIA and TIP30 function as coregulators of ERa, we performed transienttransfection experiments in Cos-1 cells with vectors expressing ERa, CIA, TIP30, and a construct containing a luciferase reporter gene controlled by the c-myc promoter (-2.3 kb 5' of P1 start site to +50 relative to P2 start site). We have constructed and prepared plasmid DNA that is necessary for transient transfection assays. As shown in Fig. IA transcription. Since western blot analyses revealed that the levels of transiently-expressed ectopic TIP30 and CIA were much higher than the levels of endogenous TIP30 and CIA in Cos-1 cells (data not shown), the effects of TIP30 and CIA on ERca-mediated transcription observed here may not represent their physiological functions. Nevertheless, these results indicate that both CIA and TIP30 are important interacting factors in modulating the activity of ERa and CIA can cooperate with TIP30 to repress ERa-mediated transcription when they are overexpressed. In view of these results, especially the inhibitory effect of ectopic TIP30, we also tested whether the complete absence of TIP30 in cells affects the transcriptional activity of ERa on the c-myc promoter. Indeed, ERcL showed a greater stimulation of the c-myc promoter in Tip30 -mouse embryonic fibroblasts (MEFs) than in Tip30' MEFs (16-fold Fig. 1B , left panel) and Tip30+l MEFs (3-fold lower). TIP30 loss also resulted in a 5-fold increase in estrogen-independent transcription from the myc prompter (Fig. 1B, left panel) . This effect was due to the absence of TIP30 since expression of TIP30 in Tip30/ cells resulted in a 42% inhibition in transcriptional activity of ERa (Fig. 1B, right panel) . The finding that deletion of the Tip30 gene elicits higher transcription from the c-myc promoter indicates that TIP30 functions to repress both estrogen-independent and ERac-mediated c-myc transcription.
To determine whether TIP30 is able to inhibit ERc-mediated transcription on a simple promoter containing the estrogen responsive element (ERE), we used an artificial promoter containing three EREs as a reporter for transient transfection assays in Tip30+,+, Tip30+l-and Tip30'-MEFs (Fig. 2) . Fig. 2A shows that loss of TIP30 results in an increased ER mediated transcription from this artificial promoter. We also observed cooperative inhibition of ERa-mediated transcription by ectopic expression of TIP30 and CIA on this promoter in Tip30/-MEFs (Fig. 2B ). This result is consistent with the observation that estrogen induces the SB. recruitment of TIP30 and Since previous studies demonstrated that ERa and coactivators (AIB 1, p300, CBP, pCAF and TRAP220) are assembled on the promoter during pre-initiation, but subsequently released during elongation (8), we next determined whether CIA and TIP30 occupy the c-myc gene during elongation. Four pairs of primers covering a region (+2196 to +2628) in exon 2 and a region (+4330 to +4685) in exon 3 were used for PCR amplification of the final DNA preparations. Binding of both TIP30 and CIA to these regions was observed in the absence of E2 (Fig. 3B, lanes 1 and 3) . E2 induction resulted in increased CIA binding (lanes 1 vs. 2), but decreased TIP30 binding (lanes 3 vs. 4) to these regions. As a positive control, binding of the largest subunit of RNA polymerase II to the regions upstream and downstream of the initiation site was also observed in both the absence and presence of E2 (Fig. 2B, lanes 9 and  10) . These results suggest that estrogen increases association of CIA with the coding regions of c-myc.
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In order to assess the specificity of association of TIP30 and CIA with the c-myc gene, we examined whether TIP30 and CIA were assembled on the promoter of the cyclin B 1 gene that is not directly regulated by ERa. As expected, RNA polymerase II is associated with the promoter (Fig. 3C, lanes 9 and 10) , but ERa is not (Lanes 7 and 8) . However, ERa, TIP30 and CIA were not associated with the promoter in either the presence or the absence of E2 (Lanes 3-6 ). In addition, non-specific antibodies from a pre-immune rabbit serum did not precipitate the DNA elements of the c-myc gene (Fig. 3D) . The protein levels of TIP30 and CIA in MCF-7 cells are not significantly changed after E2 treatment (Fig . 3E) , suggesting that E2-regulated association of TIP30 and CIA with the c-myc gene is not due to the influence of TIP30 and CIA expression by E2. Therefore, associations of these proteins with the c-myc gene are specific.
To determine whether the occupancy of the c-myc gene by TIP30 and CIA requires elongating RNA polymerase II in estrogen-dependent and independent transcription, MCF-7 cells were treated with a-amanitin, which specifically inhibits RNA polymerase II elongation, and then subjected to ChIP analysis. Consistent with the preceding observations, the occupancy of the c-myc promoter by TIP30 and CIA was not affected by a-amanitin (Fig. 3F) . In contrast, the occupancy of the coding region of the c-myc gene by TIP30 and CIA was inhibited by a-amanitin (Fig. 3E) . This result suggests that association of TIP30 and CIA with the coding regions of the c-myc gene depends on elongating RNA polymerase II.
Occupancy of ERa and RNA polymerase II on the promoter was previously shown to peak at 30-45 minutes in the first transcription cycle and at 120-150 minutes in the second cycle following the addition of E2 (8) . We therefore sought to determine the timing of TIP30 and CIA occupancy on the promoter. As was shown previously, ERCC and CBP occupancy on the promoter peaked at 30-60 min in the first transcription cycle and at 150 min in the second cycle upon E2 treatment (Fig. 3D) . The results obtained with CIA were similar to those obtained with ERa and CBP. Interestingly, TIP30 was dissociated from the promoter at 60 min and re-associated with the promoter at 120-150 min in the second cycle (Fig.  3D) . Binding of TIP30 and CIA to exon 2 was also observed at 150 min following E2 treatment (Fig. 3E) . In contrast, much less CBP was detected to associate with exon 2 upon E2 induction.
Taken together, these results demonstrate that TIP30 is associated with the c-Myc promoter, and remains with the elongation complex in the absence of E2, while association of CIA with the promoter is less evident under these conditions. Strikingly, during the first transcription cycle, estrogen induces the recruitment of CIA to, but dissociation of TIP30 from, the c-myc pronioter region. Unlike the other known ER coactivators, which are released during elongation, CIA shows an increased association with the transcribed region following E2 treatment. As was observed for ER(x and CBP, both CIA and TIP30 are associated with the promoter in the second cycle of estrogen-induced transcription. (Fig.  3E ).
Dynamic assembly of TIP30 and CIA on the cyclin D1 promoter. We next asked whether TIP30 and CIA are recruited to the promoter of cyclin D I gene that is also an ERa-targeting gene. With a ChIP assay, we found that CIA was also assembled on the cycD1 promoter in the presence of E2 (Fig. 4) . E2 induced dissociation of TIP30 from the promoter.
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TIP30 ERa Input Tamoxifen (TAM) is an antagonist of E2 that inhibits ERa-mediated transcription in MCF-7 cells. This is partly because TAM-bound ER(x recruits the N-CoR/SMRT co-repressors to the promoter and prevents recruitment ofp160, AIB 1, CBP and p300. To investigate whether TAM affects occupancy of TIP30 and CIA on the c-myc promoter, MCF-7 cells were treated with TAM and subjected to ChIP analyses. As expected, recruitment of ERc. but not CBP, to the c-myc promoter was observed (Fig. 5) . As was observed with E2, TAM induced association of CIA with the c-myc promoter but reduced TIP30 occupancy. This result suggested that CIA, but not TIP30, was present in the TAM-ERa repression complex assembled on the promoter of the c-myc gene.
Since we did not detect an increase in CycDl expression in Tip30 null mouse mammary epithelial cells, we believe that CycD1 is not a main target gene controlled by TIP30. Therefore, we decided to focus our study on Myc expression. We have completed all experiments in task 3 except experiments proposed in e. In the proposal, we planed to test TIP30 mutants made artificially in vitro for their ability to induce apoptosis. Recently, we have discovered that mutations in the TIP30 gene frequently occur in ductal carcinoma patients. We have recently identified several TIP30 mutants from ductal carcinoma patients. Therefore, we have decided to test whether those mutants are able to induce apoptosis or promote cell growth.
TIP30 and CIA act synergistically to promote cell death in MDA-MB-231 cells In order to assess the biological significance of overexpression of TIP30 and/or CIA in the growth of estrogen-independent breast cancer cells, TIP30 and CIA expression vectors were introduced into MDA-MB-231 cells. We first used TIP30 and CIA expression plasmids to make stable cell lines. We found that the efficiency of transient transfection in this cell line was very low using several commercial reagents. To efficiently introduce the expression vectors, we then constructed the pBabe-flagTIP30-puro retroviral expression vector and pBabe-CIA-puro retroviral expression vector and used 293T cells to generate replication-deficient viral particles of pBabe-puro, pBabeflagTIP30-puro, pBabe-CIA-puro, or pBabe-flagTIP30-puro and pBabe-CIA-puro. We have made stable MDA231 cells containing expressing vectors. However, we could not detect either ectopic wild-type TIP30 or ectopic CIA proteins in those cells by Western blot analysis. However, the MDA-MB-231 cells containing mutant TIP30 expression vectors overexpress mutant TIP30 proteins. This result suggests that overexpression of TIP30 or CIA was not well tolerated by these cells. Therefore, a possibility for failure of cells stably overexpressing TIP30 or CIA is that overexpression of TIP30 or CIA may suppress the growth of MDA-MB-231 cells through induction of apopotsis. To test this possibility, we examined the growth of MDA-MB-231 cells in a short-term expression assay by utilizing retroviruses expressing TIP30 and/or CIA for three days. At 48 hours after infection with retroviruses and antibiotic selections, the MDA-MB-231 cells were plated in low serum culture at equal density, and cells were counted after 36 hrs. We found that less than 2% live cells were found in the plates of MDA-MB-231 cells that had been infected with retroviruses expressing both TIP30 and CIA. Based on a preliminary study, we proposed that ectopic expression of TIP30 could cooperate with CIA to inhibit MDA-MB-231 cell growth. However, in this experiment, it was not clear whether a MDA-MB-231 cell ectopically expressed both TIP30 and CIA. In order to assure that a cell expressed both ectopic TIP30 and CIA, we have created a retrovirus expressing both TIP30 and CIA by constructing the TIP30 and CIA genes into the viral expression vector and inserting a ribosomal binding site (IRE) between the TIP30 and CIA genes that allows translation of both proteins from one mRNA. We examined the growth of MDA-MB-231 cells in a short-term expression assay by utilizing retroviruses expressing TIP30 and/or CIA. At 48 hours after infection with retroviruses and antibiotic selections, the MDA-MB-231 cells were plated in low serum culture at equal density. Proliferation and growth of cells were measured by MTT assay and counted every 24 hours for six days. As shown in Fig. 2 , proliferation of cells was not significantly affected by the retrovirus expressing TIP30 as compared to cells infected with control viruses. In contrast, proliferation of cells was significantly inhibited by retroviruses expressing CIA and completely inhibited by retroviruses expressing both CIA and TIP30. Similarly, MDA-MB-231 cells infected with control retroviruses or TIP30-expressing viruses grow at a similar rate. This data support our hypothesis that TIP30 and CIA act synergistically to predispose estrogen-independent breast cancer cells to apoptosis. 4 ................. ...................... ......................... ............................................... (Fig. 7) . In contrast, expression of either TIP30 or CIA alone resulted in 29% or 43% reduction of viable cells in comparison with control vector, respectively. Therefore, overexpression of TIP30 and CIA in cells predisposes them to apoptosis induced by cisplatin. 
Conclusions:
We demonstrate that a tumor suppressor TIP30 and an ER-interacting coactivator CIA are dynamically associated with transcription initiation and elongation complexes in response to estrogen. TIP30 overexpression represses ERca-mediated c-myc transcription, whereas TIP30 deficiency enhances c-myc transcription in the absence and presence of estrogen. Ectopic CIA cooperates with TIP30 to repress ERcx-mediated c-myc transcription. In addition, overexpression of TIP30 and CIA in estrogen-independent breast cancer cells suppresses cell growth and induces apoptosis. We suggest that TIP30 and CIA act as negative regulators to control transcription of c-myc and cyclin DI. Our data provides a new pathway for TIP30-mediated tumor suppression and sets a stage to study the mechanisms in which this cofactor regulates expression of genes that play important roles in tumorigenesis. Thus, human Tip30 may represent a new valuable diagnostic and therapeutic target for breast cancer.
